Labs Farms Rovi Sa Drug Patent Portfolio
Labs Farms Rovi Sa owns 1 orange book drug protected by 14 US patents Given below is the list of Labs Farms Rovi Sa's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10058504 | Methods for the preparation of injectable depot compositions | 31 May, 2031 | Active |
| US10085936 | Antipsychotic injectable depot composition | 31 May, 2031 | Active |
| US10182982 | Antipsychotic injectable depot composition | 31 May, 2031 | Active |
| US10195138 | Methods for the preparation of injectable depot compositions | 31 May, 2031 | Active |
| US10335366 | Risperidone or paliperidone implant formulation | 31 May, 2031 | Active |
| US10463607 | Antipsychotic Injectable Depot Composition | 31 May, 2031 | Active |
| US10881605 | Methods for the preparation of injectable depot compositions | 31 May, 2031 | Active |
| US11007139 | Risperidone or paliperidone implant formulation | 31 May, 2031 | Active |
| US11173110 | Risperidone or paliperidone implant formulation | 31 May, 2031 | Active |
| US11241377 | Antipsychotic injectable depot composition | 31 May, 2031 | Active |
| US11752092 | Methods for the preparation of injectable depot compositions | 31 May, 2031 | Active |
| US11752093 | Antipsychotic injectable depot composition | 31 May, 2031 | Active |
| US11752094 | Antipsychotic injectable depot composition | 31 May, 2031 | Active |
| US11759416 | Antipsychotic injectable depot composition | 31 May, 2031 | Active |
Labs Farms Rovi Sa's Family Patents
Labs Farms Rovi Sa Drug List
Given below is the complete list of Labs Farms Rovi Sa's drugs and the patents protecting them.
1. Risvan
Risvan is protected by 14 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10058504 | Methods for the preparation of injectable depot compositions |
31 May, 2031
(6 years from now)
| Active |
| US10085936 | Antipsychotic injectable depot composition |
31 May, 2031
(6 years from now)
| Active |
| US10182982 | Antipsychotic injectable depot composition |
31 May, 2031
(6 years from now)
| Active |
| US10195138 | Methods for the preparation of injectable depot compositions |
31 May, 2031
(6 years from now)
| Active |
| US10335366 | Risperidone or paliperidone implant formulation |
31 May, 2031
(6 years from now)
| Active |
| US10463607 | Antipsychotic Injectable Depot Composition |
31 May, 2031
(6 years from now)
| Active |
| US10881605 | Methods for the preparation of injectable depot compositions |
31 May, 2031
(6 years from now)
| Active |
| US11007139 | Risperidone or paliperidone implant formulation |
31 May, 2031
(6 years from now)
| Active |
| US11173110 | Risperidone or paliperidone implant formulation |
31 May, 2031
(6 years from now)
| Active |
| US11241377 | Antipsychotic injectable depot composition |
31 May, 2031
(6 years from now)
| Active |
| US11752092 | Methods for the preparation of injectable depot compositions |
31 May, 2031
(6 years from now)
| Active |
| US11752093 | Antipsychotic injectable depot composition |
31 May, 2031
(6 years from now)
| Active |
| US11752094 | Antipsychotic injectable depot composition |
31 May, 2031
(6 years from now)
| Active |
| US11759416 | Antipsychotic injectable depot composition |
31 May, 2031
(6 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Risvan's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List